Table 1.
Country (ASR per 100,000) | Brazil (4.5) | Canada (10.4) | Czechia (14.4) | Japan (7.6) | Lithuania (14.5) | Poland (8.1) | Romania (7.7) | Russia (10.3) | Serbia (7.4) | Thailand (1.8) | UK (10.3) | Total (4.6) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total number of cases | 96 | 73 | 259 | 36 | 16 | 13 | 64 | 216 | 69 | 5 | 115 | 962 | |
Sex | Female | 44 | 22 | 93 | 8 | 9 | 5 | 25 | 98 | 30 | 4 | 42 | 380 |
Male | 52 | 51 | 166 | 28 | 7 | 8 | 39 | 118 | 39 | 1 | 73 | 582 | |
Age at diagnosis (years) | 0–45 | 15 | 6 | 27 | 3 | 1 | 2 | 6 | 43 | 16 | 0 | 6 | 125 |
45–55 | 20 | 17 | 51 | 5 | 0 | 6 | 10 | 44 | 11 | 0 | 22 | 186 | |
55–65 | 30 | 17 | 77 | 8 | 9 | 1 | 20 | 91 | 27 | 2 | 41 | 323 | |
65–75 | 24 | 27 | 72 | 13 | 4 | 4 | 20 | 32 | 9 | 2 | 31 | 238 | |
>75 | 7 | 6 | 32 | 7 | 2 | 0 | 8 | 6 | 6 | 1 | 15 | 90 | |
Year of recruitment | 1999–2005 | 0 | 0 | 93 | 0 | 0 | 13 | 14 | 18 | 0 | 0 | 0 | 138 |
2005–2010 | 0 | 0 | 111 | 0 | 0 | 0 | 19 | 70 | 1 | 0 | 31 | 232 | |
2010–2015 | 0 | 9 | 55 | 28 | 0 | 0 | 31 | 116 | 68 | 0 | 41 | 348 | |
2015–2020 | 96 | 64 | 0 | 8 | 16 | 0 | 0 | 12 | 0 | 5 | 43 | 244 | |
Stage | I | 28 | 3 | 123 | 24 | 6 | 0 | 33 | 94 | 32 | 0 | 53 | 396 |
II | 2 | 0 | 42 | 1 | 0 | 6 | 12 | 24 | 4 | 0 | 8 | 99 | |
III | 16 | 23 | 46 | 6 | 5 | 5 | 18 | 65 | 26 | 0 | 38 | 248 | |
IV | 7 | 10 | 38 | 5 | 2 | 2 | 1 | 33 | 7 | 0 | 16 | 121 | |
Missing | 43 | 37 | 10 | 0 | 3 | 0 | 0 | 0 | 0 | 5 | 0 | 98 | |
BMI | <20 | 3 | 2 | 5 | 2 | 0 | 2 | 2 | 9 | 8 | 0 | 6 | 39 |
20–25 | 21 | 10 | 100 | 25 | 2 | 3 | 17 | 84 | 28 | 3 | 23 | 316 | |
25–30 | 35 | 24 | 85 | 7 | 6 | 6 | 30 | 40 | 20 | 1 | 45 | 299 | |
>30 | 37 | 37 | 69 | 2 | 8 | 2 | 14 | 83 | 13 | 1 | 41 | 307 | |
Missing | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | |
High blood pressure | No | 45 | 28 | 129 | 16 | 5 | 9 | 39 | 125 | 28 | 2 | 58 | 484 |
Yes | 51 | 44 | 130 | 20 | 10 | 4 | 24 | 91 | 41 | 3 | 56 | 474 | |
Missing | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 4 | |
Diabetes | No | 76 | 55 | 130 | 29 | 9 | 0 | 45 | 186 | 61 | 3 | 95 | 689 |
Yes | 20 | 16 | 36 | 7 | 7 | 0 | 4 | 12 | 8 | 2 | 20 | 132 | |
Missing | 0 | 2 | 93 | 0 | 0 | 13 | 15 | 18 | 0 | 0 | 0 | 141 | |
Family history of RCC | No | 90 | 42 | 165 | 35 | 16 | 0 | 54 | 192 | 67 | 5 | 102 | 726 |
Yes | 5 | 4 | 22 | 1 | 0 | 0 | 1 | 6 | 2 | 0 | 3 | 43 | |
Missing | 1 | 27 | 72 | 0 | 0 | 13 | 9 | 18 | 0 | 0 | 10 | 193 | |
Tobacco smoking status | Current | 23 | 21 | 66 | 9 | 4 | 6 | 11 | 52 | 18 | 1 | 28 | 239 |
Ex | 21 | 30 | 62 | 15 | 3 | 3 | 15 | 27 | 15 | 0 | 44 | 235 | |
Never | 52 | 22 | 131 | 11 | 9 | 4 | 37 | 137 | 36 | 4 | 43 | 486 | |
Missing | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 2 | |
PFOA (ng ml−1) | Mean (s.d.) | 0.7 (0.5) | 1.6 (1.1) | 3.4 (2.1) | 1.3 (0.6) | 5.4 (4.1) | 1.3 (0.9) | 1.5 (1.4) | 1.3 (0.6) | 2.2 (2.2) | 3.3 (1.7) | 2.2 (1.9) |
PFOA, perfluorooctanoic acid; RCC, renal cell carcinoma.